aldonic acid derivative - Ontology Report

2,3-Diphosphoglycerate inhibits the reaction [ARF6 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]; 2,3-Diphosphoglycerate inhibits the reaction [ARF6 protein mutant form promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides]]

PMID:10931844

NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114

Bglap

bone gamma-carboxyglutamate protein

decreases activity

2,3-Diphosphoglycerate results in decreased activity of BGLAP protein

NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495

Pld1

phospholipase D1

decreases activity

2,3-Diphosphoglycerate results in decreased activity of PLD1 protein

NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692

Sts

steroid sulfatase

multiple interactions

2,3-Diphosphoglycerate inhibits the reaction [Tretinoin results in increased activity of STS protein]

PMID:16178010

NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402

2,3-bisphosphoglyceric acid

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

Arf6

ADP-ribosylation factor 6

multiple interactions

PMID:10931844

NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114

Bglap

bone gamma-carboxyglutamate protein

decreases activity

2,3-Diphosphoglycerate results in decreased activity of BGLAP protein

NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495

Pld1

phospholipase D1

decreases activity

2,3-Diphosphoglycerate results in decreased activity of PLD1 protein

NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692

Sts

steroid sulfatase

multiple interactions

2,3-Diphosphoglycerate inhibits the reaction [Tretinoin results in increased activity of STS protein]

PMID:16178010

NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402

3-phosphoglyceric acid

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

Gapdh

glyceraldehyde-3-phosphate dehydrogenase

multiple interactions

EXP

[GAPDH protein co-treated with 3-phosphoglycerate co-treated with NAD] results in increased chemical synthesis of sodium arsenite; [GAPDH protein co-treated with 3-phosphoglycerate co-treated with NAD] results in increased reduction of sodium arsenate analog; heptelidic acid inhibits the reaction [[GAPDH protein co-treated with 3-phosphoglycerate co-treated with NAD] results in increased reduction of sodium arsenate analog]

PMID:15788719

NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235

Idh2

isocitrate dehydrogenase (NADP(+)) 2

multiple interactions
increases abundance

Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 3-phosphoglycerate]

PMID:27469509

NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025

Mapt

microtubule-associated protein tau

multiple interactions

[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of 3-phosphoglycerate; PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of 3-phosphoglycerate]